Login

Company overview with CEO | Phil Hartstein , President & CEO at FINJAN HOLDINGS, INC. 00:10:00

Share On Facebook Share On Twitter

Phil Hartstein is a President & CEO at FINJAN HOLDINGS, INC.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Invests in innovative food and agriculture companies|Andy Ziolkowski,Managing Partner,Cultivian Sandbox Ventures
00:10:00
Nighthawk Gold Corp: Developing Canada's Next Premier Gold District
00:10:00
Revolutionizing Subsurface Investigations with Electrical Resistivity Imaging
00:10:00
Interpump Unveils Innovative Solutions at IAA | Fabio Marasi - CEO of Interpump Group S.p.A.
00:10:00
Phenom Resources Advances Nevada Gold Portfolio with Active Drilling, Strategic Financing, and Multiple Upcoming Catalysts|Paul Cowley,CEO,Phenom Resources
00:00:00
The limitations of human heart transplant availability - Stéphane Piat, CEO of Carmat
00:10:00
Fortitude Gold's Projects and Future Plans
00:10:00
Dr. Francis Wedin Debunks Myths About Direct Lithium Extraction | Francis Wedin , CEO, Vulcan Energy Resources Ltd.
00:10:00
Phil Wild, Managing Director expressing about AURES Insight | Patrick Cathala, Founder, Chairman & CEO, Aures Technologies SAAURS:PAR
00:10:00
Enhancing Portfolios with Global Equity Shareholder Yield | Kera Van Valen, Portfolio Manager, Global Equity Shareholder Yield Funds | John Tobin, Portfolio Manager, Global Equity Shareholder Yield Funds
00:10:00
Turning Around Nevada Mines: Fury Gold Mines' Success Story
00:10:00
Zuora Subscribed 2017 | Tien Tzuo, CEO, Zuora IncZUO:NYQ

© 2017 - Neuhu+